Hexa Research
This presentation is the property of its rightful owner.
Sponsored Links
1 / 4

Doxorubicin Market Research Report - Industry Analysis, Size, Growth and Fo... PowerPoint PPT Presentation


Doxorubicin is an anti-cancer chemotherapy drug. It is an intravenous injection through a central or peripheral venous line. No pill form of this drug is available in the market. Doxorubicin market is expected to witness a significant growth in the developed regions due to the multiple incidences of cancer occurrence in these regions. According to World Health Organization (WHO) , in 2012, 14.1 million new cancer cases were detected worldwide.

Download Presentation

Doxorubicin Market Research Report - Industry Analysis, Size...

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Doxorubicin market research report industry analysis size growth and forecast to 2024 hexa research

Hexa Research

Fact-based market research, penetrating industry insights and validated

forecasts to help you make better decisions for a stronger future

Doxorubicin Market Analysis, Size, Share, Growth, Industry

Trends and Forecast Report up to 2024 - Hexa Research

Doxorubicin is an anti-cancer chemotherapy drug. It is an intravenous injection through

a central or peripheral venous line. No pill form of this drug is available in the market.

Doxorubicin market is expected to witness a significant growth in the developed regions

due to the multiple incidences of cancer occurrence in these regions. According to

World Health Organization (WHO), in 2012, 14.1 million new cancer cases were

detected worldwide.

Doxorubicin is an anthracycline chemotherapy drug that slows down the growth of

cancer cells which is one of the primary reasons of its demand globally.. Four most

common cancers worldwide are lung cancer, prostate cancer, female breast and bowel.

Doxorubicin drug provides chemotherapy treatment for all four cancers which is

Contact: +1-800-489-3075

Email : [email protected]

Website: http://www.hexaresearch.com/


Doxorubicin market research report industry analysis size growth and forecast to 2024 hexa research

Hexa Research

Fact-based market research, penetrating industry insights and validated

forecasts to help you make better decisions for a stronger future

anticipated to drive the industry in next eight years. Early diagnosis led to the longer

duration of treatment which in turn increases the demand for doxorubicin drug.

Increasing effectiveness of drug therapies are contributing to the higher spending on

drugs for cancer care. Moreover, various government initiatives for controlling cancer

and increasing its awareness through governmental organizations such as Cancer

Prevention And Control Research Network (CPCRN )and National Cancer Institute is

creating to have a positive impact on the anti-cancer drug. Increased alcohol

consumption, usage of tobacco coupled with lack of physical activity and unhealthy diet

are considered to be main risk factors of cancer worldwide. According to WHO

estimates, the mortality rate worldwide was 8.2 billion in 2012 and is expected to rise

by about 70% in the near future. Due to aforementioned reasons, anti-cancer drug

market revenues are anticipated to increase in the near future.

Browse Detail Report@

https://www.hexaresearch.com/upcoming-research/doxorubicin-market

Media is also playing an important role in spreading awareness about various diseases

and related drugs. Consumer awareness of these drugs is expected to have a positive

impact on the doxorubicin market. Support from non-profit organizations and regional

government in UK on approval of drugs is anticipated to drive the market during the

forecast period.

However, Doxorubicin therapy can cause a risk of developing leukemia and tumor lysis

syndrome which can further lead to kidney failure is expected to act as a roadblock for

the growth of doxorubicin market. This drug also has adverse effects and can cause

skin rashes, itchy sensation, can lead patient feel short of breath, swelling of face,

feeling dizzy and stomach ache. Moreover, it can cause extensive tissue damage and

Contact: +1-800-489-3075

Email : [email protected]

Website: http://www.hexaresearch.com/


Doxorubicin market research report industry analysis size growth and forecast to 2024 hexa research

Hexa Research

Fact-based market research, penetrating industry insights and validated

forecasts to help you make better decisions for a stronger future

can develop dizziness among consumer. High treatment cost poses a challenge to this

market. Also, pharmaceutical industries significantly rely on the R&D initiatives.

Pharmaceutical agencies are focusing on new medicines in order to cater to the

customer needs which may poses as a threat to this market in the long run.

The market can be segmented on the basis of cancer type. Doxorubicin treats number

of cancers such as acute lymphoblastic leukemia, acute myeloblastic leukemia, bone

sarcoma, breast cancer, endometrial cancer, gastric cancer, head and neck cancer,

liver cancer, kidney cancer, ovarion cancer, small cell lung cancer, thyroid cancer and

transitional cell bladder cancer. Drug used for treating thyroid cancer dominated the

market in the recent past on account of growing incidences of thyroid cancer especially

in UK.

The U.S. dominated the market in the near past on account approval of doxorubicin

products by FDA and increasing number of cancer incidences. Europe is one of the

major markets owing to increasing number of deaths due to cancer. Emerging nations

such as India and China are anticipated to show a substantial growth rate based on the

growing population, cancer incidences and tobacco consumption. Africa is expected to

observe a lower growth rate owing to lack of consumer awareness and healthcare

infrastructure, and expensive medication.

Key players in this market include Pfizer Inc., Dabur Pharmaceuticals Ltd., Cadila

Pharmaceuticals Ltd., German Remedies Ltd., Biological E Ltd., Elder Pharmaceuticals

Pvt. Ltd., Cipla Ltd., Sun Pharmaceuticals Industries Ltd., Natco Pharma Ltd., Biochem

Pharmaceutical Industries Ltd., Pharmacia India Ltd., VHB Life Science Inc., Chandra

Bhagat Pharma Pvt. Ltd., GLS Pharma Ltd., and Intas Laboratories Pvt. Ltd. Mergers

and acquisitions in this industry is helping acquirer in building technical expertise and

hold a library of patents.

Contact: +1-800-489-3075

Email : [email protected]

Website: http://www.hexaresearch.com/


Doxorubicin market research report industry analysis size growth and forecast to 2024 hexa research

Hexa Research

Fact-based market research, penetrating industry insights and validated

forecasts to help you make better decisions for a stronger future

In March 2015, Sun Pharmaceuticals Industries Ltd. acquired Ranbaxy Laboratories

Ltd. to increase its presence in the global and domestic markets by filling therapeutic

gaps in the U.S.

In February 2013, Sun Pharma’s Lipodox (doxorubicin hydrochloride liposome injection)

was approved by FDA for the treatment of ovarian cancer in the patients.

Browse Related Category Market Reports@

https://www.hexaresearch.com/research-category/pharmaceuticals-industry

About Us:

Hexa Research is a market research and consulting organization, offering industry reports,

custom research and consulting services to a host of key industries across the globe. We

offer comprehensive business intelligence in the form of industry reports which help our

clients obtain clarity about their business environment and enable them to undertake

strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: [email protected]

Website - http://www.hexaresearch.com/

Follow us on Linkedin: https://www.linkedin.com/company/hexa-research

Contact: +1-800-489-3075

Email : [email protected]

Website: http://www.hexaresearch.com/


  • Login